The document discusses the growth of pharmacovigilance in India. It notes that while pharmacovigilance is still in its infancy in India, major advancements have been made in Western countries. It outlines the benefits of developing pharmacovigilance in India, including its large population and growing economy. Challenges to pharmacovigilance in India include its predominantly rural population, extensive use of traditional medicines, and lack of awareness among physicians and consumers. The document calls for building a more robust pharmacovigilance system in India through mandatory reporting, inspections, training programs, and collaborations.